| abstract |
The present disclosure provides a nanoparticle composition comprising a prodrug of a nucleoside or nucleotide, the use of the composition as an agent, and the process of preparing the composition. The disclosure also provides the use of the nanoparticle compositions described herein as agents and / or in the manufacture of agents for the treatment of various diseases, including cancer and viral infections. In one embodiment, a composition comprising nanoparticles is provided, the nanoparticles comprising a nucleoside or nucleotide prodrug, and a pharmaceutically acceptable carrier, the pharmaceutically acceptable carrier comprising albumin. [Selection diagram] None |